| scholarly article | Q13442814 |
| P2093 | author name string | Hong Yu | |
| Zan Zhang | |||
| Haihui Sheng | |||
| Junxing Huang | |||
| Maosong Lin | |||
| Mingjun Gao | |||
| P2860 | cites work | miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. | Q50592086 |
| Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression. | Q51684920 | ||
| Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications. | Q54960825 | ||
| Mortality Trends in Colorectal Cancer in China During 2000-2015: A Joinpoint Regression and Age-Period-Cohort Analysis | Q60957470 | ||
| Colorectal cancer | Q79737976 | ||
| [uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management] | Q86091649 | ||
| The human genome browser at UCSC | Q24672361 | ||
| MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer | Q26801108 | ||
| miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma | Q28397829 | ||
| Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. | Q33644158 | ||
| Colorectal cancer statistics, 2014. | Q34660408 | ||
| Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer | Q34768088 | ||
| Impaired MicroRNA Processing Facilitates Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator Expression | Q35034871 | ||
| Inhibition of miR-193a expression by Max and RXRα activates K-Ras and PLAU to mediate distinct aspects of cellular transformation | Q35141444 | ||
| The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis | Q36090214 | ||
| Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes | Q36610815 | ||
| MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively | Q36706415 | ||
| cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer | Q37269211 | ||
| Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer | Q37432551 | ||
| Upregulated miR-193a-3p as an oncogene in esophageal squamous cell carcinoma regulating cellular proliferation, migration and apoptosis | Q37582268 | ||
| MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression | Q37660590 | ||
| Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p | Q37691771 | ||
| MicroRNAs as novel regulators of stem cell fate | Q38157933 | ||
| Involvement of urokinase-type plasminogen activator system in cancer: an overview | Q38189275 | ||
| The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies | Q38669212 | ||
| Tumor cell intravasation | Q38807918 | ||
| The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis. | Q38833520 | ||
| GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. | Q38838244 | ||
| MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway. | Q39029964 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma. | Q40558382 | ||
| Decreased expression of miR-193a-3p is associated with poor prognosis in colorectal cancer | Q40979856 | ||
| MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTEN. | Q41412784 | ||
| Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors. | Q41518094 | ||
| MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1. | Q45849909 | ||
| microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer | Q47128749 | ||
| Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis | Q47440103 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 5353-5363 | |
| P577 | publication date | 2019-06-12 | |
| P1433 | published in | Cancer Management and Research | Q5031417 |
| P1476 | title | MicroRNA-193a-3p suppresses the colorectal cancer cell proliferation and progression through downregulating the PLAU expression | |
| P478 | volume | 11 |
Search more.